• PTPN11 Gene Mutation Analysis for Noonan Syndrome
  • Complement Component CH50
  • Beta-2 Adrenergic Receptor (ADRB2) Gene Variation
  • Prostaglandin D2 (PGD2), Serum
  • Mycobacterium tuberculosis Complex, Pyrazinamide (Isoniazid, rifampin) Resistance by pncA DNA Sequencing
  • Anaplasma phagocytophilum Molecular Detection, PCR
  • Interferon B-1 (IFNB-1) Neutralizing Antibody
  • Vitamin B5 (Pantothenic Acid), Serum
  • Glucose Tolerance Test, 3 Hour Post-100g Oral Ingestion
  • Strongyloides Antibody, IgG
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Oncotype DX, Prostate Cancer
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • ICD10
  • Additional ICD10
  • References

Oncotype DX, Prostate Cancer
Medical Test

CPT
Access to Oncotype DX, Prostate Cancer is restricted.
Loading...